Angela Worby

1.3k total citations
24 papers, 576 citations indexed

About

Angela Worby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Angela Worby has authored 24 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Angela Worby's work include Phosphodiesterase function and regulation (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Angela Worby is often cited by papers focused on Phosphodiesterase function and regulation (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Angela Worby collaborates with scholars based in United Kingdom, United States and Italy. Angela Worby's co-authors include Ceri H. Davies, S. Nasir, Janet L. Davis, Julie Egerton, Harshad K. Rami, Davina E. OWEN, Andrew D. Randall, Jeffrey C. Jerman, Sarah C. Lappin and George Davey Smith and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Angela Worby

23 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Worby United Kingdom	13	269	175	135	124	109	24	576
Karl‐Heinz Buchheit Switzerland	12	233 0.9×	80 0.5×	237 1.8×	166 1.3×	83 0.8×	16	626
Mariantonella Colucci Italy	11	192 0.7×	84 0.5×	152 1.1×	148 1.2×	43 0.4×	13	552
Ádám Horváth Hungary	13	144 0.5×	144 0.8×	85 0.6×	113 0.9×	30 0.3×	35	435
Carolina García‐Martínez Spain	9	210 0.8×	308 1.8×	133 1.0×	153 1.2×	47 0.4×	9	487
Jharna R. Das United States	15	278 1.0×	37 0.2×	123 0.9×	36 0.3×	39 0.4×	36	690
Betty Yao United States	18	584 2.2×	426 2.4×	398 2.9×	224 1.8×	65 0.6×	38	1.4k
Gary W. Gullikson United States	17	260 1.0×	19 0.1×	179 1.3×	132 1.1×	192 1.8×	43	832
William Dalby‐Brown Denmark	11	268 1.0×	97 0.6×	147 1.1×	63 0.5×	37 0.3×	13	436
Hitoshi Doihara Japan	9	156 0.6×	325 1.9×	120 0.9×	135 1.1×	36 0.3×	9	707
Anu Gore United States	6	80 0.3×	198 1.1×	64 0.5×	133 1.1×	53 0.5×	8	511

Countries citing papers authored by Angela Worby

Since Specialization

Citations

This map shows the geographic impact of Angela Worby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Worby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Worby more than expected).

Fields of papers citing papers by Angela Worby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Worby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Worby. The network helps show where Angela Worby may publish in the future.

Co-authorship network of co-authors of Angela Worby

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Worby. A scholar is included among the top collaborators of Angela Worby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Worby. Angela Worby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costantino, Gabriele, Marco Mor, Fabrizio Micheli, et al.. (2013). Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3- dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists. Letters in Drug Design & Discovery. 10(5). 396–401.

Micheli, Fabrizio, Paolo Cavanni, Michela Bettati, et al.. (2011). 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors. Bioorganic & Medicinal Chemistry. 19(11). 3451–3461. 4 indexed citations

Bonanomi, Giorgio, Simone Braggio, Anna Maria Capelli, et al.. (2010). Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D₃ Receptor Antagonists. ChemMedChem. 5(5). 705–715. 16 indexed citations

Holmes, Ian P., Olivier Lorthioir, Andrew H. Payne, et al.. (2010). The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure. Bioorganic & Medicinal Chemistry Letters. 20(6). 2013–2016. 5 indexed citations

Bromidge, Steven M., Roberto Arban, Barbara Bertani, et al.. (2010). 5-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3. Bioorganic & Medicinal Chemistry Letters. 20(23). 7092–7096. 7 indexed citations

Holmes, Ian P., Fabrizio Micheli, Olivier Lorthioir, et al.. (2009). Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification. Bioorganic & Medicinal Chemistry Letters. 19(16). 4799–4801. 9 indexed citations

Micheli, Fabrizio, Ian P. Holmes, Luca Arista, et al.. (2009). Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 19(15). 4011–4013. 10 indexed citations

Micheli, Fabrizio, Giorgio Bonanomi, Simone Braggio, et al.. (2008). New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems. Bioorganic & Medicinal Chemistry Letters. 18(3). 901–907. 21 indexed citations

Micheli, Fabrizio, Giorgio Bonanomi, Simone Braggio, et al.. (2008). New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-Fused and hetero-fused systems. Bioorganic & Medicinal Chemistry Letters. 18(3). 908–912. 12 indexed citations

10.

Gentile, Gabriella, et al.. (2007). Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(18). 5218–5221. 15 indexed citations

11.

Wood, Martyn, Claire M. Scott, Nisha Patel, et al.. (2006). Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade. CNS & Neurological Disorders - Drug Targets. 5(4). 445–452. 30 indexed citations

12.

Jarvest, Richard L., Symon G. Erskine, Andrew K. Forrest, et al.. (2005). Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2305–2309. 19 indexed citations

13.

Gunthorpe, Martin J., Harshad K. Rami, Jeffrey C. Jerman, et al.. (2003). Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology. 46(1). 133–149. 220 indexed citations

14.

Turner, Nicholas C., Janine A. Lamb, Angela Worby, & Kenneth Murray. (1994). Relaxation of guinea‐pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside. British Journal of Pharmacology. 111(4). 1047–1052. 19 indexed citations

15.

Turner, Nicholas C., David C. Grimsditch, Janine A. Lamb, et al.. (1994). Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea‐pig. British Journal of Pharmacology. 111(4). 1198–1204. 4 indexed citations

16.

Coates, William J., et al.. (1993). Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogs of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase. Journal of Medicinal Chemistry. 36(10). 1387–1392. 17 indexed citations

17.

Worby, Angela, Lucy Mensah, & Kenneth Murray. (1992). Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle. Biochemical Society Transactions. 20(2). 129S–129S. 2 indexed citations

18.

Murray, Kenneth, David C. Grimsditch, Bella Patel, et al.. (1992). The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function. British Journal of Pharmacology. 107(2). 463–470. 20 indexed citations

19.

Murray, Kenneth, P. England, David C. Grimsditch, et al.. (1991). Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.. PubMed. 34. 27–46. 15 indexed citations

20.

Worby, Angela, Lucy Mensah, & Kenneth Murray. (1991). Identification of the novel rat liver IBMX-insensitive phosphodiesterase as a non-specific phosphodiesterase capable of hydrolysing cCMP. Biochemical Pharmacology. 42(6). 1318–1321. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact